Company profile

Bright Peak Therapeutics AG

Bright Peak is developing next-generation engineered cytokines for immuno-oncology indications.

Bright Peak Therapeutics AG

Source: startup.ch

Highlights

Top 100 Swiss Startup Award 2022Top 100 Swiss Startup Award 2022

More news about Bright Peak Therapeutics AG

21.03.2022 12:01

Seasoned Board Members for Swiss Startups
  • Success
    Please login or
    register to use the
    awards follow feature
    14.06.2021 09:42

    Bright Peak Therapeutics Closes $107 Million Financing Round
  • Financing
    Please login or
    register to use the
    awards follow feature
    29.07.2020 16:40

    Bright Peak off to a good start with $35 million from Versant Ventures
  • Financing
  • Launch
    Please login or
    register to use the
    awards follow feature
    Bright Peak Therapeutics AG

    Founded
    2017

    Kanton
    BS


    LinkedIn

    Homepage

    rss